Prometheus Biosciences, Inc. RXDX
Set alert
199.92 +199.92 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 9.56B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -44.33
- Beta
- -0.49
- Short ratio
- 3.97
- Inst. own
- 81.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 10, 2023
- 50-d avg
- 189.46
- 200-d avg
- 112.93
- 1y target
- 190.00
Discussion (6)
Sign in to join the discussion
Camy CK RXDX 3 years ago #1If you missed out here come to $NCMI???????????
Nick Wronski RXDX 3 years ago #2Cramer is talking about it, they are toast ??
Nick Wronski RXDX 3 years ago #3TIMBBERRRRRRRR HOOOOO ???
Nick Wronski RXDX 3 years ago #4100 eod
Nick Wronski RXDX 3 years ago #5Great company with great research, these prices are completely reasonable with a full approved drug, but right now it’s respectfully a 65-75 dollar stock.
Nick Wronski RXDX 3 years ago #6Great run coming to an end, market isn’t feasible to hold these prices